Bambi A. Clay, PA-C

Bambi Clay practices at Diagnostic Laboratory of Oklahoma in Oklahoma City, Oklahoma.

Bambi Clay's NPI, 1922077049, was assigned on March 14, 2006. Bambi Clay holds Oklahoma license 1343.

Bambi Clay's primary practice is Diagnostic Laboratory of Oklahoma, at 225 Ne 97th Street, Oklahoma City, OK 73114. The practice phone is (405) 608-6100.

Bambi Clay's primary practice is Diagnostic Laboratory of Oklahoma in Oklahoma City, Oklahoma. Bambi Clay is also affiliated with Paris Regional Health. The medical group on file is ACS Primary Care Physicians Southwest, PA. Dmand AI also links Bambi Clay to 1 more hospital, 2 clinical labs, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bambi Clay practices, 6 sites in all. Vendor and product names are available with a free account.

Physician assistant is Bambi Clay's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Dmand AI has Bambi Clay's licenses on file in 2 states: Oklahoma and Texas.

CMS counts 15 Medicare patients who saw Bambi Clay in 2024. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 0.82, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Bambi Clay's median patient age at 54, with 59% women.

In 2024, Bambi Clay wrote 2,986 Medicare Part D claims for 250 patients. 89% of them were for generic drugs. CMS names the drug for 2,377 of them, across 66 drugs with 11 or more claims each, at $145,317 in total drug cost.

Bambi Clay accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Bambi Clay from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Exact Sciences Corporation paid the most, $17.